DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactIPO

Sahajanand Medical Technologies IPO Subscription Status

IPO Watch 10 hrs ago·15 Oct 2026, 10:30 am

IPO IPO Watch

Sahajanand Medical Technologies has successfully concluded its initial public offering (IPO). The issue, which opened for subscription on June 20 and closed on June 24, received a strong response from investors. The company raised capital to fund its expansion plans and for general corporate purposes. This move allows the medical device manufacturer to strengthen its balance sheet as it looks to grow its market presence.

For investors, the IPO's oversubscription indicates significant demand for the company's shares. This suggests that the market views Sahajanand's growth prospects positively. Retail investors who applied for shares may be allocated a portion of the issue, depending on the final allotment process. The listing of these shares on the stock exchange will be a key event to watch for price movements.

Investors should monitor the company's financial performance and the overall market sentiment post-listing. The stock's trading debut will provide insights into how the market values the company at this stage. It is advisable to keep an eye on the company's future announcements and quarterly results to gauge its progress.